J Am Coll Radiol
Key takeaways GLP-1s, initially developed to help manage and treat diabetes and later used to treat obesity, are now showing significant potential to help prevent and treat other conditions
Risk of diabetic retinopathy between sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists (Diabetes Metab J 2023;47:394-404)
Is it safe to drink alcohol while taking Wegovy
Here's what should be on the panel baseline, then every 90 days: Metabolic markers: fasting glucose, HbA1c, fasting insulin, lipid panel (with apoB if available)
Herkenne S, Ek O, Zamberlan M, Pellattiero A, Chergova M, Chivite I, et al